scholarly journals Retinal vein occlusion with cerebral infarction in a preterm neonate: a case report

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Xiuyu Zhu ◽  
Xiaojing Cai ◽  
Xiaohong Zhou ◽  
Yian Li ◽  
Chenhao Yang

Abstract Background Retinal vein occlusion (RVO) is a common disease that causes blindness in elderly patients, and cerebral infarction is also a severe disorder impairing the health of individuals. Both diseases are not common in neonates and are related to thrombosis. To date, only one case of simultaneous occurrence of RVO with intracranial haemorrhage in a full-term neonate has been reported. Case presentation A preterm neonate was diagnosed with cerebral infarction and RVO. Retinal haemorrhage and macular oedema were detected in the left eye after the onset of ipsilateral stroke. Although the retinal conditions in this case resolved spontaneously without ocular treatment, the long-term effect on visual function is still unknown. Conclusions Given that ocular fundus examinations are rarely performed in paediatric stroke patients, a screening fundus examination in these newborns with stroke might be worth considering.

PLoS ONE ◽  
2019 ◽  
Vol 14 (9) ◽  
pp. e0222895 ◽  
Author(s):  
Han-Wei Zhang ◽  
Chao-Wen Lin ◽  
Victor C. Kok ◽  
Chun-Hung Tseng ◽  
Yuan-Pei Lin ◽  
...  

2017 ◽  
Vol 8 (1) ◽  
pp. 271-278 ◽  
Author(s):  
Thomas Bertelmann ◽  
Hans Ulrich Frank ◽  
Hendrik Ansgar Fuchs ◽  
Nicolas Feltgen

Purpose: To report a case with ischemic macular edema (ME) due to an acute branch retinal vein occlusion (BRVO) which was treated with repeated intravitreal anti-VEGF injections. Methods: Retrospective case presentation. Results: A 66-year-old female patient was treated with repeated intravitreal anti-VEGF injections due to ischemic ME following an acute BRVO. Over a period of 2.5 years best corrected visual acuity increased from 0.06 to 0.6 (decimal notation) accompanied by a reduction in central retinal thickness from 546 to 292 µm. Overall 17 anti-VEGF injections were administered to treat repeated recurrence of ME. Macular ischemia did not worsen during this profound intravitreal anti-VEGF therapy. Conclusion: Intravitreal anti-VEGF therapy can be a beneficial treatment strategy even in ischemic ME following an acute BRVO.


2009 ◽  
Vol 247 (12) ◽  
pp. 1635-1641 ◽  
Author(s):  
Alexandra E. Hoeh ◽  
Thomas Ach ◽  
Karen B. Schaal ◽  
Alexander F. Scheuerle ◽  
Stefan Dithmar

2009 ◽  
Vol 223 (5) ◽  
pp. 313-319 ◽  
Author(s):  
Josep Callizo ◽  
Peter Kroll ◽  
Stefan Mennel ◽  
Joerg C. Schmidt ◽  
Carsten H. Meyer

Sign in / Sign up

Export Citation Format

Share Document